Literature DB >> 21350559

HLA homozygosity and haplotype bias among patients with chronic lymphocytic leukemia: implications for disease control by physiological immune surveillance.

N Shah, W K Decker, R Lapushin, D Xing, S N Robinson, H Yang, S Parmar, S S Tung, S O'Brien, M Fernandez-Viña, E J Shpall, W G Wierda.   

Abstract

Entities:  

Mesh：

Year:  2011        PMID： 21350559     DOI： 10.1038/leu.2011.30

Source DB:  PubMed          Journal:  Leukemia        ISSN： 0887-6924            Impact factor:   11.528


× No keyword cloud information.
  10 in total

1.  Erroneous HLA typing as a result of acquired uniparental disomy in a patient with acute lymphoblastic leukaemia in peripheral blood complete remission.

Authors:  Andrea Bontadini; Sandra Iannelli; Fiorenza Fruet; Simonetta Capelli; Riccardo Masetti; Valérie Dubois; Jean-Marie Tiercy; Arcangelo Prete
Journal:  Blood Transfus       Date:  2015-01-29       Impact factor: 3.443

2.  Reduced intensity conditioning regimens including alkylating chemotherapy do not alter survival outcomes after allogeneic hematopoietic cell transplantation in chronic lymphocytic leukemia compared to low-intensity non-myeloablative conditioning.

Authors:  Niels Smedegaard Andersen; Martin Bornhäuser; Martin Gramatzki; Peter Dreger; Antonin Vitek; Michal Karas; Mauricette Michallet; Carol Moreno; Michel van Gelder; Anja Henseler; Liesbeth C de Wreede; Stefan Schönland; Nicolaus Kröger; Johannes Schetelig
Journal:  J Cancer Res Clin Oncol       Date:  2019-08-29       Impact factor: 4.553

3.  Genomic variation by whole-genome SNP mapping arrays predicts time-to-event outcome in patients with chronic lymphocytic leukemia: a comparison of CLL and HapMap genotypes.

Authors:  Carmen D Schweighofer; Kevin R Coombes; Tadeusz Majewski; Lynn L Barron; Susan Lerner; Rachel L Sargent; Susan O'Brien; Alessandra Ferrajoli; William G Wierda; Bogdan A Czerniak; L Jeffrey Medeiros; Michael J Keating; Lynne V Abruzzo
Journal:  J Mol Diagn       Date:  2012-12-27       Impact factor: 5.568

4.  Fine-mapping of HLA associations with chronic lymphocytic leukemia in US populations.

Authors:  Loren Gragert; Stephanie Fingerson; Mark Albrecht; Martin Maiers; Matt Kalaycio; Brian T Hill
Journal:  Blood       Date:  2014-09-17       Impact factor: 22.113

5.  Restricted T cell receptor repertoire in CLL-like monoclonal B cell lymphocytosis and early stage CLL.

Authors:  Gonzalo Blanco; Anna Vardi; Anna Puiggros; Andrea Gómez-Llonín; Manuel Muro; María Rodríguez-Rivera; Evangelia Stalika; Eugenia Abella; Eva Gimeno; Manuela López-Sánchez; Alicia Senín; Xavier Calvo; Pau Abrisqueta; Francesc Bosch; Ana Ferrer; Kostas Stamatopoulos; Blanca Espinet
Journal:  Oncoimmunology       Date:  2018-02-20       Impact factor: 8.110

6.  Donor Killer Cell Immunoglobulin-Like Receptor Genotype Does Not Improve Graft-versus-Leukemia Responses in Chronic Lymphocytic Leukemia after Unrelated Donor Transplant: A Center for International Blood and Marrow Transplant Research Analysis.

Authors:  Veronika Bachanova; Daniel J Weisdorf; Tao Wang; Steven G E Marsh; Nezih Cereb; Michael D Haagenson; Stephen R Spellman; Stephanie J Lee; Lisbeth A Guethlein; Peter Parham; Jeffrey S Miller; Sarah A Cooley
Journal:  Biol Blood Marrow Transplant       Date:  2018-12-27       Impact factor: 5.742

7.  HLA Class I and II Diversity Contributes to the Etiologic Heterogeneity of Non-Hodgkin Lymphoma Subtypes.

Authors:  Sophia S Wang; Mary Carrington; Sonja I Berndt; Susan L Slager; Paige M Bracci; Jenna Voutsinas; James R Cerhan; Karin E Smedby; Henrik Hjalgrim; Joseph Vijai; Lindsay M Morton; Roel Vermeulen; Ora Paltiel; Claire M Vajdic; Martha S Linet; Alexandra Nieters; Silvia de Sanjose; Wendy Cozen; Elizabeth E Brown; Jennifer Turner; John J Spinelli; Tongzhang Zheng; Brenda M Birmann; Christopher R Flowers; Nikolaus Becker; Elizabeth A Holly; Eleanor Kane; Dennis Weisenburger; Marc Maynadie; Pierluigi Cocco; Demetrius Albanes; Stephanie J Weinstein; Lauren R Teras; W Ryan Diver; Stephanie J Lax; Ruth C Travis; Rudolph Kaaks; Elio Riboli; Yolanda Benavente; Paul Brennan; James McKay; Marie-Hélène Delfau-Larue; Brian K Link; Corrado Magnani; Maria Grazia Ennas; Giancarlo Latte; Andrew L Feldman; Nicole Wong Doo; Graham G Giles; Melissa C Southey; Roger L Milne; Kenneth Offit; Jacob Musinsky; Alan A Arslan; Mark P Purdue; Hans-Olov Adami; Mads Melbye; Bengt Glimelius; Lucia Conde; Nicola J Camp; Martha Glenn; Karen Curtin; Jacqueline Clavel; Alain Monnereau; David G Cox; Hervé Ghesquières; Gilles Salles; Paulo Bofetta; Lenka Foretova; Anthony Staines; Scott Davis; Richard K Severson; Qing Lan; Angela Brooks-Wilson; Martyn T Smith; Eve Roman; Anne Kricker; Yawei Zhang; Peter Kraft; Stephen J Chanock; Nathaniel Rothman; Patricia Hartge; Christine F Skibola
Journal:  Cancer Res       Date:  2018-05-07       Impact factor: 13.312

8.  HLA specificities are associated with prognosis in IGHV-mutated CLL-like high-count monoclonal B cell lymphocytosis.

Authors:  María García-Álvarez; Miguel Alcoceba; Miriam López-Parra; Noemí Puig; Alicia Antón; Ana Balanzategui; Isabel Prieto-Conde; Cristina Jiménez; María E Sarasquete; M Carmen Chillón; María Laura Gutiérrez; Rocío Corral; José María Alonso; José Antonio Queizán; Julia Vidán; Emilia Pardal; María Jesús Peñarrubia; José M Bastida; Ramón García-Sanz; Luis Marín; Marcos González
Journal:  PLoS One       Date:  2017-03-01       Impact factor: 3.240

9.  HLA Diversity in Saudi Population: High Frequency of Homozygous HLA Alleles and Haplotypes.

Authors:  Aziz Alami Chentoufi; F Aytül Uyar; Hiba A Chentoufi; Khalid Alzahrani; Maria Paz; Ahmed Bahnassy; Ghaleb Elyamany; Assem Elghazaly
Journal:  Front Genet       Date:  2022-06-09       Impact factor: 4.772

10.  Generation of functional CLL-specific cord blood CTL using CD40-ligated CLL APC.

Authors:  William K Decker; Nina Shah; Dongxia Xing; Ruth Lapushin; Sufang Li; Simon N Robinson; Hong Yang; Simrit Parmar; Matthew M Halpert; Michael J Keating; John G Gribben; Jeffrey J Molldrem; Elizabeth J Shpall; William G Wierda
Journal:  PLoS One       Date:  2012-12-19       Impact factor: 3.240
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.